サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1409743

キノロンの世界市場レポート 2024年

Quinolones Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
キノロンの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

キノロン市場規模は近年着実に成長しています。2023年の483億1,000万米ドルから2024年には506億5,000万米ドルに、CAGR4.9％で拡大します。過去の期間に観察された成長は、抗生物質の需要とその使用量、規制当局の承認、研究開発活動、製薬業界内の競合情勢、特許切れなどの要因に起因しています。

キノロンの市場規模は、今後数年間で安定した成長が見込まれます。2028年の年間平均成長率（CAGR）は5.0％で、615億1,000万米ドルに成長します。予測期間中に予想される成長は、新たな疾患の出現、規制の変更、世界の保健政策、抗生物質耐性への課題の増加、市場拡大戦略などの要因に起因すると考えられます。予測期間に予想される主な動向には、医学研究の進歩や転換、ヘルスケア政策の変化、抗生物質耐性に対処するための戦略の進化などが含まれます。

キノロン市場の成長は、感染症の発生率の増加に大きく起因しています。寄生虫、真菌、細菌、ウイルスなどの微生物によって引き起こされる感染症は、依然として世界の健康課題となっています。キノロンは、結核や尿路感染症など様々な細菌感染症の治療に広く使用されており、こうした健康上の懸念に対処する上で重要な役割を果たしています。例えば、汎米保健機構（Pan American Health Organization）が提供した2022年のデータによると、2021年には約1,060万人が結核に罹患し、4.5％増加しました。このように、感染症の急増はキノロン市場の成長の原動力となっています。

抗菌薬耐性の増加が予想されることも、キノロン市場の継続的成長に寄与しています。微生物が抗菌薬の効果に抵抗する能力である抗菌薬耐性（AMR）は、公衆衛生に重大な脅威をもたらします。キノロンは、様々な細菌に対する幅広い活性スペクトルと有効性を持ち、選択肢が限られている場合に好ましい選択肢となります。2022年11月、英国健康安全保障局は、2021年にイングランドで予測される重度の抗生物質耐性感染症の総数が2.2％増加したと報告しました。このことは、抗菌薬耐性の危険性が高まっていることを浮き彫りにしており、キノロンの需要を押し上げています。

2023年のキノロン市場では北米が最大地域でした。キノロン市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 キノロン市場の特徴

第3章 キノロン市場の動向と戦略

第4章 キノロン市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界のキノロン市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 キノロン市場セグメンテーション

  • 世界のキノロン市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • ノルフロキサシン
  • オフロキサシン
  • シプロフロキサシン
  • ゲミフロキサシン
  • その他のタイプ
  • 世界のキノロン市場、病原体タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • グラム陽性病原体
  • グラム陰性病原体
  • 世界のキノロン市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第7章 キノロン市場の地域および国分析

  • 世界のキノロン市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界のキノロン市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋のキノロン市場

第9章 中国のキノロン市場

第10章 インドのキノロン市場

第11章 日本のキノロン市場

第12章 オーストラリアのキノロン市場

第13章 インドネシアのキノロン市場

第14章 韓国のキノロン市場

第15章 西欧のキノロン市場

第16章 英国のキノロン市場

第17章 ドイツのキノロン市場

第18章 フランスのキノロン市場

第19章 イタリアのキノロン市場

第20章 スペインのキノロン市場

第21章 東欧のキノロン市場

第22章 ロシアのキノロン市場

第23章 北米キノロン市場

第24章 米国のキノロン市場

第25章 カナダのキノロン市場

第26章 南米キノロン市場

第27章 ブラジルのキノロン市場

第28章 中東のキノロン市場

第29章 アフリカのキノロン市場

第30章 キノロン市場の競合情勢と企業プロファイル

  • キノロン市場の競合情勢
  • キノロン市場の企業プロファイル
    • Bayer AG
    • Novartis AG
    • Sanofi SA
    • Johnson &Johnson Services Inc.
    • Merck &Co. Inc.

第31章 世界のキノロン市場の競合ベンチマーキング

第32章 世界のキノロン市場競争力ダッシュボード

第33章 キノロン市場における主要な合併と買収

第34章 キノロン市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r11281

“Quinolones Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on quinolones market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quinolones? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The quinolones market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Norfloxacin; Ofloxacin; Ciprofloxacin; Gemifloxacin; Other Types
  • 2) By Pathogen Type: Gram-Positive Pathogen; Gram-Negative Pathogen
  • 3) By Application: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • Companies Mentioned: Bayer AG; Novartis AG; Sanofi SA; Johnson & Johnson Services Inc.; Merck & Co. Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Quinolones are a class of bactericidal antibiotics that exhibit the capability to directly kill bacterial cells, targeting both gram-positive and gram-negative bacteria. They are employed in the treatment of various infectious diseases caused by bacteria.

The primary types of quinolones include norfloxacin, ofloxacin, ciprofloxacin, gemifloxacin, and others. Norfloxacin, specifically a fluoroquinolone, is utilized for the treatment of diverse bacterial infections. Its applications extend to addressing conditions such as conjunctivitis and urinary tract infections, targeting both gram-positive and gram-negative pathogens. Quinolones are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The quinolones market research report is one of a series of new reports from The Business Research Company that provides, quinolones market statistics, including, quinolones industry global market size, regional shares, competitors with a quinolones market share, detailed, quinolones market segments, market trends and opportunities, and any further data you may need to thrive in the quinolones industry. This, quinolones market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The quinolones market size has grown steadily in recent years. It will grow from $48.31 billion in 2023 to $50.65 billion in 2024 at a compound annual growth rate (CAGR) of 4.9%. The growth observed in the historical period can be attributed to factors such as the demand for antibiotics and their usage, regulatory approvals, research and development activities, the competitive landscape within the pharmaceutical industry, and the expiration of patents.

The quinolones market size is expected to see steady growth in the next few years. It will grow to $61.51 billion in 2028 at a compound annual growth rate (CAGR) of 5.0%. The anticipated growth in the forecast period can be attributed to factors such as the emergence of new diseases, regulatory changes, global health policies, the increasing challenge of antibiotic resistance, and market expansion strategies. Key trends expected in the forecast period may include advancements or shifts in medical research, changes in healthcare policies, and evolving strategies to address antibiotic resistance.

The growth of the quinolones market is significantly attributed to the increasing incidence of infectious diseases. Infectious diseases, caused by microbes such as parasites, fungi, bacteria, and viruses, remain a global health challenge. Quinolones, widely employed in treating various bacterial infections such as tuberculosis and urinary tract infections, play a crucial role in addressing these health concerns. For example, data from 2022 provided by the Pan American Health Organization indicated that approximately 10.6 million people contracted tuberculosis (TB) in 2021, marking a 4.5% increase. Thus, the upsurge in infectious diseases is a driving force behind the growth of the quinolones market.

The anticipated rise in antimicrobial resistance contributes to the continued growth of the quinolones market. Antimicrobial resistance (AMR), the ability of microorganisms to resist the effects of antimicrobial drugs, poses a significant threat to public health. Quinolones, with their broad spectrum of activity and effectiveness against various bacteria, become a preferred choice in cases of limited options. Notably, in November 2022, the United Kingdom Health Security Agency reported a 2.2% increase in the predicted total number of severe antibiotic-resistant infections in England in 2021. This highlights the growing danger of antimicrobial resistance, which is propelling the demand for quinolones.

A prominent trend in the quinolones market is the emphasis on product innovation by major companies to sustain their market positions. For instance, in January 2023, Viatris, a US-based pharmaceutical company's South Korean branch introduced Dovprela, a novel treatment for drug-resistant tuberculosis. Dovprela, a three-drug regimen comprising bedaquiline, pretomanid, and linezolid (BPaL), offers a more rapid anti-tuberculosis effect, reducing the treatment period from 18-20 months to 5-6 months. This innovation addresses the pressing need for effective and efficient tuberculosis treatments.

Innovative products, such as fluoroquinolone antibiotic eye drops, are being introduced to drive revenues in the quinolones market. Fluoroquinolone antibiotic eye drops, a class of antibiotics targeting bacterial eye infections, contribute to ophthalmic health. For instance, Harrow Health Inc., a US-based pharmaceutical company, launched Vigamox in July 2023. This sterile ophthalmic solution, delivered in a 3-milliliter bottle, is indicated for the prevention of eye infections before and after surgery. Such innovative products cater to diverse medical needs and contribute to the market's growth.

In June 2023, Bausch + Lomb Incorporated, a US-based eye health company, acquired Novartis International AG for an undisclosed amount. Through this acquisition, Bausch + Lomb aims to restructure its pharmaceutical division, enhancing its scale and positioning it at the forefront of addressing ocular surface disorders. The acquisition diversifies Bausch + Lomb's product portfolio, introducing new opportunities such as libvatrep and AcuStream technology. Libvatrep is an experimental compound studied for treating chronic ocular surface pain, while AcuStream technology is an experimental device designed for accurate dosing and delivery of certain topical ophthalmic medications. Novartis International AG, based in Switzerland, is a pharmaceutical company with a global presence.

Major companies operating in the quinolones market report are Bayer AG, Novartis AG, Sanofi SA, Johnson & Johnson Services Inc., Merck & Co. Inc., LG Life Sciences, Allergan Inc., Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, Bausch Health Companies Inc., KYORIN Holdings Inc., MerLion Pharmaceuticals GmbH, Teva Pharmaceutical Industries Ltd., GSK plc, AbbVie Inc., Zee Laboratories, Cipla Ltd., Bhavishya Pharmaceuticals, Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, Novus, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Mylan N.V., Wockhardt Ltd

North America was the largest region in the quinolones market in 2023. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the quinolones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quinolones market consists of sales of bedaquiline. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Quinolones Market Characteristics

3. Quinolones Market Trends And Strategies

4. Quinolones Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Quinolones Market Size and Growth

  • 5.1. Global Quinolones Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Quinolones Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Quinolones Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Quinolones Market Segmentation

  • 6.1. Global Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Norfloxacin
  • Ofloxacin
  • Ciprofloxacin
  • Gemifloxacin
  • Other Types
  • 6.2. Global Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Gram-Positive Pathogen
  • Gram-Negative Pathogen
  • 6.3. Global Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

7. Quinolones Market Regional And Country Analysis

  • 7.1. Global Quinolones Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Quinolones Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Quinolones Market

  • 8.1. Asia-Pacific Quinolones Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Quinolones Market

  • 9.1. China Quinolones Market Overview
  • 9.2. China Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Quinolones Market

  • 10.1. India Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Quinolones Market

  • 11.1. Japan Quinolones Market Overview
  • 11.2. Japan Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Quinolones Market

  • 12.1. Australia Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Quinolones Market

  • 13.1. Indonesia Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Quinolones Market

  • 14.1. South Korea Quinolones Market Overview
  • 14.2. South Korea Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Quinolones Market

  • 15.1. Western Europe Quinolones Market Overview
  • 15.2. Western Europe Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Quinolones Market

  • 16.1. UK Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Quinolones Market

  • 17.1. Germany Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Quinolones Market

  • 18.1. France Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Quinolones Market

  • 19.1. Italy Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Quinolones Market

  • 20.1. Spain Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Quinolones Market

  • 21.1. Eastern Europe Quinolones Market Overview
  • 21.2. Eastern Europe Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Quinolones Market

  • 22.1. Russia Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Quinolones Market

  • 23.1. North America Quinolones Market Overview
  • 23.2. North America Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Quinolones Market

  • 24.1. USA Quinolones Market Overview
  • 24.2. USA Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Quinolones Market

  • 25.1. Canada Quinolones Market Overview
  • 25.2. Canada Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Quinolones Market

  • 26.1. South America Quinolones Market Overview
  • 26.2. South America Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Quinolones Market

  • 27.1. Brazil Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Quinolones Market

  • 28.1. Middle East Quinolones Market Overview
  • 28.2. Middle East Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Quinolones Market

  • 29.1. Africa Quinolones Market Overview
  • 29.2. Africa Quinolones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Quinolones Market, Segmentation By Pathogen Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Quinolones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Quinolones Market Competitive Landscape And Company Profiles

  • 30.1. Quinolones Market Competitive Landscape
  • 30.2. Quinolones Market Company Profiles
    • 30.2.1. Bayer AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Novartis AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Sanofi SA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Johnson & Johnson Services Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Merck & Co. Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Quinolones Market Competitive Benchmarking

32. Global Quinolones Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Quinolones Market

34. Quinolones Market Future Outlook and Potential Analysis

  • 34.1 Quinolones Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Quinolones Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Quinolones Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer